Allogene Therapeutics Inc - ALLO - stock price prediction, stock price target, analyst ratings from 15 analysts

Allogene Therapeutics Inc has a share price target of US$ 7, revenue growth forecast of -50.0%, and profit growth estimate of 22.0% for FY26, based on top 15 analyst calls.